Advertisement

Topics

Search Results for "Pharma New Product Launch India"

14:00 EST 14th February 2016 | BioPortfolio

Matching Channels

India

India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

India ink colloidal carbon stain

Eligard

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

Matching News

Ajanta Pharma Announces the Launch of Montelukast IR Tablets and Montelukast Chewable Tablets

BRIDGEWATER, N.J., Dec. 3, 2015 /PRNewswire/ -- Ajanta Pharma USA Inc., a subsidiary of Ajanta Pharma Limited, India, announced today the launch of Montelukast Sodium IR Tablets (10mg) and M...

India Plans Park for 50 China Pharmas

Pharma City, a new pharma park intended especially for China pharmas, is being established in India, near Hyderabad. Eventually, the site is expected to house manufacturing facilities for 50 China pha...

Rituximab similar biologic launched in India

India-based generics maker Hetero Group (Hetero) announced on 3 August 2015 the launch of its product Maball, a ‘similar biologic’ of rituximab, in India.

Ajanta Pharma Announces the Launch of Montelukast Sodium Oral Granules

BRIDGEWATER, N.J., Nov. 16, 2015 /PRNewswire/ -- Ajanta Pharma USA Inc., a subsidiary of Ajanta Pharma Limited, announced today the launch of Montelukast Sodium Oral Granules (4mg), a b...

TVM Capital: Investments from Scotland to India

In the last in the series of interviews from the BIA Leadership Summit, Dr Fintan Walton talks to Simon Best, Entrepreneur-in-House at TVM Capital. Simon’s background was in agriculture. He is based...

Torrent Pharma Forays Into Super Specialty Segment And Launches Adfrar – Biosimilar Adalimumab

Ahmedabad based Torrent Pharma enters New Year 2016 by announcing the launch of biosimilar Adalimumab in India under the brand name ‘Adfrar’.

Asia's biggest vaccine maker to seek fast-track nod for dengue drug in India

MUMBAI, Sept 22 (Reuters) - Asia's largest vaccine maker, Serum Institute of India, plans to file for fast-track approval to launch a dengue treatment in India, its chief executive said, potentially b...

Pharma contract manufacturing on the rise in India

The past few decades have been very productive for India, as it took a major leap from pharmaceutical…

Matching PubMed Articles

Pharma Success in Product Development-Does Biotechnology Change the Paradigm in Product Development and Attrition.

The biotechnology segment of the overall biopharma industry has existed for only about 40-45 years, as a driver of new product development. This driving force was initiated with the FDA approval of r...

10 years after implementation of TRIPS obligations in India.

The Patent (Amendment) Act of 2005 enforced after TRIPS raises many issues which hinder growth of Indian pharma companies. To tackle this, Indian pharma companies doubled their R&D expenditure and bec...

THE LAUNCH WINDOW HYPOTHESIS AND THE SPEED-ACCURACY TRADE-OFF IN BASEBALL THROWING (.)

-The speed-accuracy trade-off in throwing has been well described, but its cause is poorly understood. The popular impulse-variability hypothesis lacks relevance to throwing, while the launch window h...

Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India.

In 2002, the Meningitis Vaccine Project (MVP) chose the Serum Institute of India, Ltd (SIIL), as its manufacturing partner to establish a product development partnership (PDP) with the Meningitis Vacc...

Digital health revolution: Perfect storm or perfect opportunity for pharmaceutical R&D?

The convergence of technology and medicine has pushed healthcare to the brink of a major disruption that pharma has, until recently, been slow to recognize. Tech players have pioneered the emerging fi...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement